If you like investing in individual stocks and exchange-traded funds (ETFs), chances are you're fami...
The offers and details on this page may have updated or changed since the time of publication. See o...
Nvidia (NASDAQ: NVDA) dominates the artificial intelligence (AI) chip market, and this has helped ea...
One of the most exciting things to do as an investor is to look at what famed institutional investor...
My daughter just graduated from college and is preparing to start her first "real job." The other da...
AstraZeneca (NASDAQ: AZN), recognized as the world's sixth-largest pharmaceutical entity by market c...
Palantir Technologies (NYSE: PLTR) is one of the more popular stocks among investors but also one of...
Image source: Upsplash/The Motley Fool
Hybrid trucks are becoming more popular as they offer the ...
In 2022, the market had a terrible year, which was likely because of the aggressive rate hikes insti...
One of the best things to happen to stock investing, in my opinion, is the creation of exchange-trad...
Dividend growth stocks have a proven track record as value creators. Several factors contribute to t...
Archer Aviation (NYSE: ACHR) stands at the forefront of the aviation industry's transformation, pion...
Vanguard Information Technology Index Fund ETF (NYSEMKT: VGT) has risen around 35% over the past yea...
Tracking what hedge funds are doing can be an excellent check when determining your investment strat...
Image source: Getty Images
As of this writing, the highest-paying CDs on our radar have maturity ...
The good thing about retirement is that there's no uniform way people should approach it. Some use i...
Over the last few years, many large technology companies have chosen to split their stock. Notable e...
The Nasdaq Composite index has climbed over 30% in the last 12 months, primarily driven by tech stoc...
Many investors have soured on Lemonade (NYSE: LMND) over the past four years. The online insurer wen...
Image source: Upsplash/The Motley Fool
For several years now, my credit score has been my pride a...
Since its spinoff from Pfizer in 2013, animal healthcare behemoth Zoetis (NYSE: ZTS) has seen its ca...